Skip to main content

Vijoice

Pronunciation: vi’ joiz
Generic name: alpelisib
Dosage form: tablets (50 mg, 125 mg, 200 mg), granules (50 mg)
Drug class: PI3K inhibitors

Medically reviewed by Melisa Puckey, BPharm. Last updated on Sep 16, 2024.

What is Vijoice?

Vijoice (alpelisib) is a treatment for PIK3CA-Related Overgrowth Spectrum (PROS), to help reduce overgrowth and improve PROS symptoms or prevent them from worsening. Vijoice is a targeted therapy from a class of medicines called oral kinase inhibitors. Vijoice works by inhibiting the PI3K pathway, one of the most important intracellular pathways involved in cell proliferation, cell regulation, and cell death.

Vijoice granules or tablets are taken once daily.

PROS is a spectrum of rare conditions characterized by abnormal overgrowth and structural abnormalities in blood vessels, the lymphatic system, and other tissues. PROS is caused by a mutation in the PIK3CA gene, which results in cells growing and dividing abnormally. 

Vijoice FDA-approval indication is for the treatment of patients with severe phosphatidylinositol-3-kinase catalytic subunit alpha (PIK3CA)-Related Overgrowth Spectrum (PROS), who require systemic therapy and are 2 years of age and older. It was approved on April 6, 2022, under an accelerated approval designation, and continued approval may be subject to favorable results from further clinical trials. 

Piqray vs Vijoice

Vijoice and Piqray contain the same active ingredient, alpelisib, but are FDA-approved for different conditions. Piqray is FDA-approved to treat types of breast cancer in men and postmenopausal women. Vijoice (alpelisib) is FDA-approved to treat PIK3CA-Related Overgrowth Spectrum (PROS). Piqray and Vijoice are both distributed by Novartis Pharmaceuticals Corporation.

Vijoice side effects

The most common Vijoice side effects are diarrhea, high blood sugar, dry skin, mouth sores (stomatitis), headache and hair loss (alopecia).

Serious side effects include:

Severe allergic reactions. Tell your healthcare provider or get medical help right away if you have trouble breathing, flushing, rash, fever, or fast heart rate during treatment.

Severe skin reactions. Tell your healthcare provider or get medical help right away if you get severe rash or rash that keeps getting worse, reddened skin, flu-like symptoms, blistering of the lips, eyes or mouth, blisters on the skin or skin peeling, with or without fever.

High blood sugar levels (hyperglycemia). Hyperglycemia is common with Vijoice and can be severe. Your healthcare provider will monitor your sugar levels before you start, and during treatment. Your healthcare provider may monitor your sugar levels more often if you have a history of diabetes. Tell your healthcare provider right away if you develop symptoms of hyperglycemia, including:

Lung problems (pneumonitis). Tell your healthcare provider right away if you develop new or worsening symptoms of lung problems, including:

Diarrhea or  inflammation of your intestines (colitis). Diarrhea is common with Vijoice and can be severe. Severe diarrhea can lead to the loss of too much body water (dehydration) and kidney injury. Tell your healthcare provider right away if you develop diarrhea, stomach-area (abdominal) pain, or see mucus or blood in your stool during treatment with this medicine. during treatment. Your healthcare provider may tell you to drink more fluids or take medicines to treat diarrhea or colitis.

Fertility This medicine may affect fertility in males and in females who can become pregnant. Talk to your healthcare provider if this is a concern for you. 

Your healthcare provider may tell you to decrease your dose, temporarily stop your treatment, or completely stop your treatment if you get certain serious side effects.

These are not all of the possible side effects. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Before you take Vijoice

Do not take Vijoice if you have had a severe allergic reaction to alpelisib, Piqray or are allergic to any of the inactive ingredients.

Before you start treatment, tell your healthcare provider about all of your medical conditions, including if you:

Pregnancy

Tell your Doctor or healthcare provider if you are pregnant or plan to become pregnant. Vijoice can harm your unborn baby.
Females who are able to become pregnant:

Males with female partners who are able to become pregnant:

Breastfeeding

Tell your Doctor or healthcare provider if you are breastfeeding or plan to breastfeed. It is not known if Vijoice passes into your breast milk. Do not breastfeed during treatment, and for 1 week after the last dose.

How should I take Vijoice?

Vijoice Tablet Instructions

Vijoice Granule Instructions

Each packet is for single use only. Do not use the packet if the packet seal is broken.

Open the packet of Vijoice granules by holding them with the cut line on top.

Vijoice granules may be taken in one of the following ways:

Vijoice Dosing information

Usual Adult Dosage for PIK3CA-Related Overgrowth Spectrum

Usual Pediatric Dosage for PIK3CA-Related Overgrowth Spectrum

Doses may be modified due to side effects.

Click on the link below for more detailed dosing information.

Vijoice Dosage Forms and Strengths

Vijoice Tablets: 50 mg, 125 mg, and 200 mg

Vijoice Granules: 50 mg 

Vijoice Package Insert 

Review the Vijoice Package Insert (Prescribing Information) for more detailed information about this medicine. Discuss any medical questions you have with your doctor or other health care provider. This is not all the information you need to know about this medicine for safe and effective use, and it does not take the place of talking to your doctor about your treatment.

What other drugs will affect Vijoice?

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Vijoice and other medicines may affect each other causing side effects. Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get
a new medicine.

Storage

Keep all medicines out of the reach of children and pets.

Ingredients

Vijoice tablets

Active ingredient: alpelisib
Inactive ingredients: hypromellose, magnesium stearate, mannitol, microcrystalline cellulose, and sodium starch glycolate.

Film-coating: contains hypromellose, iron oxide red (applicable only to 50 mg and 200 mg strengths), iron oxide yellow, macrogol/polyethylene glycol (PEG) 4000, talc, and titanium dioxide.

Vijoice granules

Active ingredient: alpelisib
Inactive ingredients: hypromellose, magnesium stearate, mannitol, microcrystalline cellulose, and sodium starch glycolate.

Manufacturer

Vijoice Novartis Pharmaceuticals Corporation.

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.